GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
GlycoMimetics reports 2018 executive compensation
By ExecPay News
Published: April 10, 2019
GlycoMimetics reported fiscal year 2018 executive compensation information on April 10, 2019.
In 2018, four executives at GlycoMimetics received on average a compensation package of $1.9M, a 86% increase compared to previous year.
Average pay of disclosed executives at GlycoMimetics
Rachel K. King, Chief Executive Officer, received $3.2M in total, which increased by 105% compared to 2017. 74% of King's compensation, or $2.4M, was in option awards. King also received $287K in non-equity incentive plan, $543K in salary, as well as $5.2K in other compensation.
Helen M. Thackray, Chief Medical Officer, received a compensation package of $1.6M, which increased by 71% compared to previous year. 63% of the compensation package, or $1M, was in option awards.
John L. Magnani, Chief Scientific Officer, earned $1.6M in 2018, a 76% increase compared to previous year.
Brian M. Hahn, Chief Financial Officer, received $1.4M in 2018, which increases by 75% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 10, 2019.